Cited by CrossRef (6)

  1. Nahal Abbasi, Yasaman Mirabzadeh, Golnaz Khesali, Zahra Ebrahimkhani, Hanie Karimi, Salar Vaseghi. Chronic REM sleep deprivation leads to manic- and OCD-related behaviors, and decreases hippocampal BDNF expression in female rats. Psychopharmacology 2024;241:1345
    https://doi.org/10.1007/s00213-024-06566-0
  2. Neeraj Kumar Sethiya, Neha Ghiloria, Akanksha Srivastav, Dheeraj Bisht, Sushil Kumar Chaudhary, Vaibhav Walia, Md. Sabir Alam. Therapeutic Potential of Myricetin in the Treatment of Neurological, Neuropsychiatric, and Neurodegenerative Disorders. CNSNDDT 2024;23:865
    https://doi.org/10.2174/1871527322666230718105358
  3. Jun-Yu Yang, Yi-Xuan Ma, Yan Liu, Xiang-Jun Peng, Xiang-Zhao Chen. A Comprehensive Review of Natural Flavonoids with Anti-SARS-CoV-2 Activity. Molecules 2023;28:2735
    https://doi.org/10.3390/molecules28062735
  4. Jie Gao, Lina Zhao, Dedong Li, Yun Li, Haiyun Wang. Enriched environment ameliorates postsurgery sleep deprivation‐induced cognitive impairments through the AMPA receptor GluA1 subunit. Brain and Behavior 2023;13
    https://doi.org/10.1002/brb3.2992
  5. A.S. Chiriapkin. Myricetin as a Promising Flavonoid with Multitargeted Biological Activity. 2024;10:5
    https://doi.org/10.32415/jscientia_2024_10_1_5-18
  6. Aruna Sharma, Lianyuan Feng, Dafin F. Muresanu, Z. Ryan Tian, José Vicente Lafuente, Anca D. Buzoianu, Ala Nozari, Igor Bryukhovetskiy, Igor Manzhulo, Lars Wiklund, Hari Shanker Sharma. Nanowired Delivery of Drugs and Antibodies for Neuroprotection in Brain Diseases with Co-morbidity Factors. 2024.
    https://doi.org/10.1016/bs.irn.2023.05.009